GSC
BIOA

Ground Swell Capital’s BioAmber Inc. BIOA Stock Holding History

Ground Swell Capital’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-200
Closed -$2K – 3026
2014
Q2 		$2K Buy
+200
New +$2.06K ﹤0.01% 1599

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ground Swell Capital's BIOA Position: Q3 2014 in Review

Ground Swell Capital sold out of BioAmber Inc. (BIOA) in Q3 2014, closing a stake of 200 shares — an estimated $2K sold.

Ground Swell Capital first reported a position in BIOA in Q2 2014 and held it in 1 quarter. The position peaked at $2K in Q2 2014. 27 funds tracked by Wall St. Rank hold BIOA as of Q3 2014.

  • Ground Swell Capital reported no remaining BioAmber Inc. position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 200 BioAmber Inc. shares in Q3 2014, an estimated $2K.
  • Ground Swell Capital first reported a position in BioAmber Inc. in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's BioAmber Inc. position peaked at $2K in Q2 2014.
  • 27 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.